TickerFacts.

SAB Biotherapeutics, Inc. (SABS): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2024-03-29. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

61.34M
Year ended 2025-12-31
+141.5%
3-year compound annual growth
2020-12-31: 27.01M2021-12-31: 27.34M2022-12-31: 4.35M2023-12-31: 5.52M2024-12-31: 9.26M2025-12-31: 61.34M61.34M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3161.34M+562.3%2026-03-09, From 2025-01-01
2024-12-319.26M+67.7%2026-03-09, From 2024-01-01
2023-12-315.52M+26.9%2025-03-31, From 2023-01-01
2022-12-314.35Mn/c2024-03-29, From 2022-01-01
2021-12-3127.34M+1.2%2023-04-28, From 2021-01-01
2020-12-3127.01Mn/a2023-04-28, From 2020-01-01